Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization

NCT ID: NCT03591172

Last Updated: 2018-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-30

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will assess different irrigating materials on the success revascularization of necrotic mature teeth associated with PRF.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nano-propolis and Propolis will be used as final endodontic irrigants and will be compared to saline in Revascularization of necrotic mature teeth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-operative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

propolis

natural antibacterial, anti-inflammatory irrigation solution

Group Type EXPERIMENTAL

Propolis

Intervention Type DRUG

Using propolis as a final irrigation in revascularization

Nano-propolis

natural antibacterial, anti-inflammatory irrigation solution

Group Type EXPERIMENTAL

Nano-propolis

Intervention Type DRUG

Using Nano-propolis as a final irrigation in revasculariztion

saline

sodium chloride irrigation solution

Group Type ACTIVE_COMPARATOR

saline

Intervention Type DRUG

Using saline as a final irrigation in revasculariztion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propolis

Using propolis as a final irrigation in revascularization

Intervention Type DRUG

Nano-propolis

Using Nano-propolis as a final irrigation in revasculariztion

Intervention Type DRUG

saline

Using saline as a final irrigation in revasculariztion

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

natural irrigant Natural irrigant sodium chloride

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* mature teeth.
* teeth with periapical periodontitis.
* Maxillary anterior teeth
* Patients should be free from any systemic disease
* Patients who will agree to the consent and will commit to follow-up period.

Exclusion Criteria

* Patients with immature roots.
* Patients with any systemic disease that may affect normal healing.
* Patients with swelling. .Pregnant females. .Patients who could/would not participate in a 1-year follow-up. .Patients with fistula. .Patients with old age. .Teeth with periodontal involvement. .Teeth with vertical root fractures. .Non-restorable teeth.
Minimum Eligible Age

15 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maha Ahmed Nassar

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEBD_CU_2018_05_29

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.